T/HENANPA 010-2023 Active Group standards

T/HENANPA 010-2023 The evaluation index system for statin drugs in medical institutions

T/HENANPA 010-2023 The evaluation index system for statin drugs in medical institutions

Publish Date: 2023-08-11 Implement Date: 2023-08-18 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Download

Basic Information

Standard Code: T/HENANPA 010-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2023-08-11
Implement Date: 2023-08-18
Pages: 21 pages

Scope

Main technical content: The "Evaluation Index System for Statins in Medical Institutions" follows the principles of openness, transparency, and fairness. It is based on relevant guidelines and combines the characteristics of clinical drug use. It widely adopts the opinions of drug users, monitors, and managers in medical institutions, and the evaluation standards are highly scientific, specific, and timely. They can be used as a reference by medical institutions at all levels. It is conducive to promoting the selection of drug lists in medical and health institutions and the connection between drug lists of higher and lower-level medical and health institutions, improving the level of pharmaceutical services and rational use of statins, controlling unreasonable drug expenditure, and enhancing the efficiency of health resource allocation. It has great application value.

Development Information

Pages: 21 pages

Related Standards

Contact Us